PURPOSE: Prostate cancer can be treated by radical prostatectomy (RP) and provoke a troublesome side effect: urinary incontinence (UI). We propose a verification of the usefulness of MRI and an identification of which structures are involved in UI after RP. METHODS: Between September 2002 and December 2011, 550 patients underwent RP. We performed MRI to evaluate extraprostatic disease before surgery. To evaluate patient status, we measured the following structures: length (LP), width (WP), height (HP) and volume (PV) of the prostate, membranous urethral length (MUL), urethral wall thickness (UWT), levator ani muscle (LAM) and obturator internus muscle (OIM) thickness, ratio of levator ani muscle/prostate volume (LAM/PV), volume of the urethra (VU). UI was defined according to ICS definition as the complaint of any involuntary leakage of urine and evaluated 1 year after surgery. Analyses were performed by mean comparisons, univariate and multivariate logistic regression with a 1000-resample bootstrapping. RESULTS: Means of measurements were: LP 4.46 cm, WP 5.15 cm, HP 3.9 cm, PV 49.3 cc; LAM 0.51 cm, OIM 1.46 cm; MUL 1.43 cm, UWT 1.38 cm; and LAM/PV 0.013 cm/cc, VU 2.33 cc. One hundred and twenty-two (22.2 %) patients complained of urine leakage. Univariate obtained differences in PV, OIM, MUL, and UWT. After adjusting by confounders, multivariate analysis showed: MUL: [OR 0.134; CI 95 % (0.022-0.493); P 0.006]; PV: [OR 1.016; CI 95 % (1.004-1.029); P 0.005]; UWT: [OR 6.03; CI 95 % (1.068-44.1); P 0.033]. CONCLUSIONS: MRI is a useful tool to predict UI after RP. The MUL and PV are well-identified structures that are involved in UI. Our study shows that UWT also influences UI.
PURPOSE:Prostate cancer can be treated by radical prostatectomy (RP) and provoke a troublesome side effect: urinary incontinence (UI). We propose a verification of the usefulness of MRI and an identification of which structures are involved in UI after RP. METHODS: Between September 2002 and December 2011, 550 patients underwent RP. We performed MRI to evaluate extraprostatic disease before surgery. To evaluate patient status, we measured the following structures: length (LP), width (WP), height (HP) and volume (PV) of the prostate, membranous urethral length (MUL), urethral wall thickness (UWT), levator ani muscle (LAM) and obturator internus muscle (OIM) thickness, ratio of levator ani muscle/prostate volume (LAM/PV), volume of the urethra (VU). UI was defined according to ICS definition as the complaint of any involuntary leakage of urine and evaluated 1 year after surgery. Analyses were performed by mean comparisons, univariate and multivariate logistic regression with a 1000-resample bootstrapping. RESULTS: Means of measurements were: LP 4.46 cm, WP 5.15 cm, HP 3.9 cm, PV 49.3 cc; LAM 0.51 cm, OIM 1.46 cm; MUL 1.43 cm, UWT 1.38 cm; and LAM/PV 0.013 cm/cc, VU 2.33 cc. One hundred and twenty-two (22.2 %) patients complained of urine leakage. Univariate obtained differences in PV, OIM, MUL, and UWT. After adjusting by confounders, multivariate analysis showed: MUL: [OR 0.134; CI 95 % (0.022-0.493); P 0.006]; PV: [OR 1.016; CI 95 % (1.004-1.029); P 0.005]; UWT: [OR 6.03; CI 95 % (1.068-44.1); P 0.033]. CONCLUSIONS: MRI is a useful tool to predict UI after RP. The MUL and PV are well-identified structures that are involved in UI. Our study shows that UWT also influences UI.
Authors: Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein Journal: Neurourol Urodyn Date: 2002 Impact factor: 2.696
Authors: Dong Wan Sohn; Chan Kyu Hong; Dong Jin Chung; Sun Ho Kim; Soo Jin Kim; Jinsoo Chung; Jae Young Joung; Kang Hyun Lee; Ho Kyung Seo Journal: J Magn Reson Imaging Date: 2013-09-10 Impact factor: 4.813
Authors: Ricarda M Bauer; Christian Gozzi; Wilhelm Hübner; Victor W Nitti; Giacomo Novara; Andrew Peterson; Jaspreet S Sandhu; Christian G Stief Journal: Eur Urol Date: 2011-03-21 Impact factor: 20.096
Authors: Chang Wook Jeong; Jong Jin Oh; Seong Jin Jeong; Sung Kyu Hong; Seok-Soo Byun; Sung Il Hwang; Hak Jong Lee; Sang Eun Lee Journal: World J Urol Date: 2012-03-24 Impact factor: 4.226
Authors: Christian von Bodman; Kazuhito Matsushita; Caroline Savage; Mika P Matikainen; James A Eastham; Peter T Scardino; Farhang Rabbani; Oguz Akin; Jaspreet S Sandhu Journal: J Urol Date: 2012-01-20 Impact factor: 7.450
Authors: Vincenzo Ficarra; Giacomo Novara; Raymond C Rosen; Walter Artibani; Peter R Carroll; Anthony Costello; Mani Menon; Francesco Montorsi; Vipul R Patel; Jens-Uwe Stolzenburg; Henk Van der Poel; Timothy G Wilson; Filiberto Zattoni; Alexandre Mottrie Journal: Eur Urol Date: 2012-06-01 Impact factor: 20.096
Authors: Sean F Mungovan; Jaspreet S Sandhu; Oguz Akin; Neil A Smart; Petra L Graham; Manish I Patel Journal: Eur Urol Date: 2016-07-06 Impact factor: 20.096
Authors: M E O'Callaghan; E Raymond; J Campbell; A D Vincent; K Beckmann; D Roder; S Evans; J McNeil; J Millar; J Zalcberg; M Borg; K Moretti Journal: Prostate Cancer Prostatic Dis Date: 2017-06-06 Impact factor: 5.554
Authors: Hannah Lamberg; Prasad R Shankar; Karandeep Singh; Elaine M Caoili; Arvin K George; Caitlin Hackett; Anna Johnson; Matthew S Davenport Journal: Radiology Date: 2022-01-18 Impact factor: 29.146
Authors: Mike Wenzel; Felix Preisser; Matthias Mueller; Lena H Theissen; Maria N Welte; Benedikt Hoeh; Clara Humke; Simon Bernatz; Boris Bodelle; Christoph Würnschimmel; Derya Tilki; Hartwig Huland; Markus Graefen; Frederik C Roos; Andreas Becker; Pierre I Karakiewicz; Felix K H Chun; Luis A Kluth; Philipp Mandel Journal: Int Urol Nephrol Date: 2021-02-19 Impact factor: 2.370